Literature DB >> 20812729

Identification of selective norbornane-type aspartate analogue inhibitors of the glutamate transporter 1 (GLT-1) from the chemical universe generated database (GDB).

Erika Luethi1, Kong T Nguyen, Marc Bürzle, Lorenz C Blum, Yoshiro Suzuki, Matthias Hediger, Jean-Louis Reymond.   

Abstract

A variety of conformationally constrained aspartate and glutamate analogues inhibit the glutamate transporter 1 (GLT-1, also known as EAAT2). To expand the search for such analogues, a virtual library of aliphatic aspartate and glutamate analogues was generated starting from the chemical universe database GDB-11, which contains 26.4 million possible molecules up to 11 atoms of C, N, O, F, resulting in 101026 aspartate analogues and 151285 glutamate analogues. Virtual screening was realized by high-throughput docking to the glutamate binding site of the glutamate transporter homologue from Pyrococcus horikoshii (PDB code: 1XFH ) using Autodock. Norbornane-type aspartate analogues were selected from the top-scoring virtual hits and synthesized. Testing and optimization led to the identification of (1R*,2R*,3S*,4R*,6R*)-2-amino-6-phenethyl-bicyclo[2.2.1]heptane-2,3-dicarboxylic acid as a new inhibitor of GLT-1 with IC(50) = 1.4 μM against GLT-1 and no inhibition of the related transporter EAAC1. The systematic diversification of known ligands by enumeration with help of GDB followed by virtual screening, synthesis, and testing as exemplified here provides a general strategy for drug discovery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20812729     DOI: 10.1021/jm100959g

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

Review 1.  Exploring chemical space for drug discovery using the chemical universe database.

Authors:  Jean-Louis Reymond; Mahendra Awale
Journal:  ACS Chem Neurosci       Date:  2012-04-25       Impact factor: 4.418

2.  Visualisation and subsets of the chemical universe database GDB-13 for virtual screening.

Authors:  Lorenz C Blum; Ruud van Deursen; Jean-Louis Reymond
Journal:  J Comput Aided Mol Des       Date:  2011-05-27       Impact factor: 3.686

3.  Defining substrate and blocker activity of alanine-serine-cysteine transporter 2 (ASCT2) Ligands with Novel Serine Analogs.

Authors:  Thomas Albers; William Marsiglia; Taniya Thomas; Armanda Gameiro; Christof Grewer
Journal:  Mol Pharmacol       Date:  2011-11-23       Impact factor: 4.436

4.  Mechanism of inhibition of the glutamate transporter EAAC1 by the conformationally constrained glutamate analogue (+)-HIP-B.

Authors:  Randolph Callender; Armanda Gameiro; Andrea Pinto; Carlo De Micheli; Christof Grewer
Journal:  Biochemistry       Date:  2012-06-27       Impact factor: 3.162

5.  Stochastic voyages into uncharted chemical space produce a representative library of all possible drug-like compounds.

Authors:  Aaron M Virshup; Julia Contreras-García; Peter Wipf; Weitao Yang; David N Beratan
Journal:  J Am Chem Soc       Date:  2013-05-02       Impact factor: 15.419

Review 6.  SLC transporters as therapeutic targets: emerging opportunities.

Authors:  Lawrence Lin; Sook Wah Yee; Richard B Kim; Kathleen M Giacomini
Journal:  Nat Rev Drug Discov       Date:  2015-06-26       Impact factor: 84.694

7.  Yeast synthetic biology platform generates novel chemical structures as scaffolds for drug discovery.

Authors:  Jens Klein; Jonathan R Heal; William D O Hamilton; Thiamo Boussemghoune; Thomas Østergaard Tange; Fanny Delegrange; Georg Jaeschke; Anaëlle Hatsch; Jutta Heim
Journal:  ACS Synth Biol       Date:  2014-01-30       Impact factor: 5.110

8.  Inhibitors of Human Divalent Metal Transporters DMT1 (SLC11A2) and ZIP8 (SLC39A8) from a GDB-17 Fragment Library.

Authors:  Jonai Pujol-Giménez; Marion Poirier; Sven Bühlmann; Céline Schuppisser; Rajesh Bhardwaj; Mahendra Awale; Ricardo Visini; Sacha Javor; Matthias A Hediger; Jean-Louis Reymond
Journal:  ChemMedChem       Date:  2021-08-31       Impact factor: 3.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.